Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ares Management CorpARES · Entity 3048 | Director | July 30, 2026 | August 04, 2026 |
| MATTEL INC /DE/MAT · Entity 1046 | Director | May 28, 2026 | June 01, 2026 |
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ares Management Corp
Report date July 30, 2026 · Filed August 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 31,462 |
Reported balance
After 2026-07-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-07-30 · Grant · Acquired 1,728 · Balance 31,462 F1: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date. F2: Includes 1,728 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary of the grant date.
F2: Includes 1,728 restricted units granted under an equity incentive plan of Ares Management Corporation. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement.
MATTEL INC /DE/
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,753 |
Reported balance
After 2026-05-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-28 · Grant · Acquired 11,753 · Balance 11,753 F1: The Restricted Stock Units ("RSUs" or "Units") were granted on May 28, 2026 pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. The RSUs are accompanied by dividend equivalent rights. F2: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units ("RSUs" or "Units") were granted on May 28, 2026 pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. The RSUs are accompanied by dividend equivalent rights.
F2: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant or such later date in accordance with the terms of the Mattel, Inc. Deferred Compensation Plan for Non-Employee Directors. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Mattel, Inc. Common Stock.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 760 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 760 · Balance 760 F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2: Annual non-employee director award. F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. F4: Not applicable as restricted stock units do not have an expiration date. |
| Common StockSEC Table I · non-derivative | Direct | 5,555 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,555 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F2: Annual non-employee director award.
F3: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
F4: Not applicable as restricted stock units do not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2023 Filed Jul 7, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010951 · form4-07072023_040715.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 07, 2023 Filed Jul 7, 2023 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010951 · form4-07072023_040715.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| May 23, 2023 Filed May 26, 2023 01:39 UTC | Ares Management Corp ARES · Entity 3048 | SaleClass A Common Stock | 1,200 | $85.59 | $102,708.00 |
DisclosureSEC source: 0001628280-23-019861 · wk-form4_1685065161.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,997 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold on May 23, 2023 in multiple transactions at prices ranging from $85.56 to $85.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 5,137 restricted units granted under the Third Amended and Restated 2014 Equity Incentive Plan. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| May 15, 2023 Filed May 18, 2023 00:54 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 8,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-23-000058 · wf-form4_168437123565750.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,594 Underlying: Common Stock · 8,594 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on May 15, 2023, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of such share on the settlement date). The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| January 03, 2023 Filed Jan 3, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,150 | $276.26 | $317,699.00 |
DisclosureSEC source: 0001415889-23-000058 · form4-01032023_040114.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,505 F1 · kind: This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| December 09, 2022 Filed Dec 9, 2022 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,010 | $282.00 | $284,820.00 |
DisclosureSEC source: 0001415889-22-012321 · form4-12092022_041211.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,655 Read SEC document |
| November 08, 2022 Filed Nov 9, 2022 00:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 600 | $265.09 | $159,054.00 |
DisclosureSEC source: 0001415889-22-011203 · form4-11092022_121115.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,665 Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 00:03 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 1,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-011203 · form4-11092022_121115.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,265 F1 · price: Bona fide charitable contribution to a donor advised fund. Read SEC document |
| July 28, 2022 Filed Jul 30, 2022 01:32 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 2,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-019872 · wf-form4_165914473877834.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,197 F1 · shares: Granted under the Ares Management Corporation Third Amended and Restated 2014 Equity Incentive Plan (the "Equity Incentive Plan"). Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse on the first anniversary on July 28, 2023. F2 · balance_after: Includes 6,185 restricted units granted under the Equity Incentive Plan. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Disposition to issuerRestricted Stock Unit · Derivative | 2,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007600 · form4-07082022_020726.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,160 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| July 08, 2022 Filed Jul 8, 2022 21:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007600 · form4-07082022_020726.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 21:40 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007600 · form4-07082022_020726.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 10,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-22-007019 · form4-06282022_040602.xml · derivative · entry 4 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 700 | $241.00 | $168,702.03 |
DisclosureSEC source: 0001415889-22-007019 · form4-06282022_040602.xml · nonDerivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $241.00 to $241.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 9,300 | $240.29 | $2,234,737.92 |
DisclosureSEC source: 0001415889-22-007019 · form4-06282022_040602.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,930 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $240.00 to $240.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $175.43 | $1,754,300.00 |
DisclosureSEC source: 0001415889-22-007019 · form4-06282022_040602.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 10,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-22-005695 · form4-05262022_040501.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 10,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 10,000 | $226.46 | $2,264,638.00 |
DisclosureSEC source: 0001415889-22-005695 · form4-05262022_040501.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230 F1 · price: This transaction was executed in multiple trades at prices ranging from $226.185 to $226.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 26, 2022 Filed May 26, 2022 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 10,000 | $175.43 | $1,754,300.00 |
DisclosureSEC source: 0001415889-22-005695 · form4-05262022_040501.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:44 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 6,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-22-000064 · wf-form4_165368421353996.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,843 Underlying: Common Stock · 6,843 shares Expires not disclosed F2 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on May 25, 2022, pursuant to the Plan. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs are accompanied by dividend equivalent rights. F3 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock. F3 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:44 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantCommon Stock | 4,636 | $22.65 | $105,005.40 |
DisclosureSEC source: 0001523711-22-000064 · wf-form4_165368421353996.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,721 F1 · price: The Reporting Person was granted shares of Common Stock pursuant to the Mattel, Inc. 2010 Equity and Long-Term Compensation Plan, as amended (the "Plan"), in lieu of cash director fees at the election of the Reporting Person. Read SEC document |
| May 16, 2022 Filed May 18, 2022 21:45 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionRestricted Stock Units · Derivative | 12,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-22-000044 · wf-form4_165291008612847.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As reported on a Form 4 dated May 16, 2019 and filed on May 20, 2019, the Reporting Person received a grant of 12,567 Restricted Stock Units ("RSUs") on May 16, 2019. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 16, 2022, 100% of these RSUs were settled, resulting in the issuance of 12,567 shares of Mattel, Inc. Common Stock. F1 · derivative.exercise_date: As reported on a Form 4 dated May 16, 2019 and filed on May 20, 2019, the Reporting Person received a grant of 12,567 Restricted Stock Units ("RSUs") on May 16, 2019. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 16, 2022, 100% of these RSUs were settled, resulting in the issuance of 12,567 shares of Mattel, Inc. Common Stock. F1 · derivative.expiration_date: As reported on a Form 4 dated May 16, 2019 and filed on May 20, 2019, the Reporting Person received a grant of 12,567 Restricted Stock Units ("RSUs") on May 16, 2019. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 16, 2022, 100% of these RSUs were settled, resulting in the issuance of 12,567 shares of Mattel, Inc. Common Stock. Read SEC document |
| May 16, 2022 Filed May 18, 2022 21:45 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionCommon Stock | 12,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001523711-22-000044 · wf-form4_165291008612847.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As reported on a Form 4 dated May 16, 2019 and filed on May 20, 2019, the Reporting Person received a grant of 12,567 Restricted Stock Units ("RSUs") on May 16, 2019. The RSUs were fully vested on the grant date and are settled on the third anniversary of the grant date. On May 16, 2022, 100% of these RSUs were settled, resulting in the issuance of 12,567 shares of Mattel, Inc. Common Stock. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 21:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 920 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-143605 · tm2133880-3_4seq1.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,230 F1 · price: Bona fide charitable contribution to a donor advised fund. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:50 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionRestricted Stock Units · Derivative | 6,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-21-000068 · wf-form4_163165259950280.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,518 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As reported on a Form 4 dated September 13, 2018 and filed on September 14, 2018, the Reporting Person received a grant of 6,518 Restricted Stock Units ("RSUs") on September 13, 2018. The RSUs were fully vested on the grant date. On September 13, 2021, 100% of these RSUs were settled, resulting in the issuance of 6,518 shares of Mattel Common Stock. F1 · derivative.exercise_date: As reported on a Form 4 dated September 13, 2018 and filed on September 14, 2018, the Reporting Person received a grant of 6,518 Restricted Stock Units ("RSUs") on September 13, 2018. The RSUs were fully vested on the grant date. On September 13, 2021, 100% of these RSUs were settled, resulting in the issuance of 6,518 shares of Mattel Common Stock. F1 · derivative.expiration_date: As reported on a Form 4 dated September 13, 2018 and filed on September 14, 2018, the Reporting Person received a grant of 6,518 Restricted Stock Units ("RSUs") on September 13, 2018. The RSUs were fully vested on the grant date. On September 13, 2021, 100% of these RSUs were settled, resulting in the issuance of 6,518 shares of Mattel Common Stock. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 20:50 UTC | MATTEL INC /DE/ MAT · Entity 1046 | Exercise / conversionCommon Stock | 6,518 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001523711-21-000068 · wf-form4_163165259950280.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: As reported on a Form 4 dated September 13, 2018 and filed on September 14, 2018, the Reporting Person received a grant of 6,518 Restricted Stock Units ("RSUs") on September 13, 2018. The RSUs were fully vested on the grant date. On September 13, 2021, 100% of these RSUs were settled, resulting in the issuance of 6,518 shares of Mattel Common Stock. Read SEC document |
| July 27, 2021 Filed Jul 30, 2021 01:22 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-014963 · wf-form4_162760811303997.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,410 F1 · shares: Granted under the Ares Management Corporation Third Amended and Restated 2014 Equity Incentive Plan (the "Equity Incentive Plan"). Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are schedule to lapse in three equal installments on July 27, 2022, 2023 and 2024. F2 · balance_after: Includes 6,032 restricted units granted under the Equity Incentive Plan. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 20:49 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 2,160 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-021757 · form4.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,160 Underlying: Common Stock · 2,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders. F3 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 3,360 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020802 · form4.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2021 Filed Jun 29, 2021 20:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020802 · form4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| May 26, 2021 Filed May 28, 2021 22:31 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 7,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-21-000036 · wf-form4_162224107070600.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,539 Underlying: Common Stock · 7,539 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on May 26, 2021, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of such share on the settlement date). The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 13:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 4,207 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001127602-21-012654 · form4.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,207 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 13:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 4,207 | $184.96 | $778,126.72 |
DisclosureSEC source: 0001127602-21-012654 · form4.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,790 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 13:33 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,207 | $76.36 | $321,246.52 |
DisclosureSEC source: 0001127602-21-012654 · form4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,103 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001127602-21-011542 · form4.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,207 Underlying: Common Stock · 2,103 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,103 | $170.00 | $357,510.00 |
DisclosureSEC source: 0001127602-21-011542 · form4.xml · nonDerivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,790 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:32 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,103 | $76.36 | $160,585.08 |
DisclosureSEC source: 0001127602-21-011542 · form4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:40 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 3,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-012191 · wf-form4_159683991993078.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,457 F1 · shares: Granted under the Ares Management Corporation Second Amended and Restated 2014 Equity Incentive Plan (the "Equity Incentive Plan"). Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are schedule to lapse in three equal installments on August 5, 2021, 2022 and 2023. F2 · balance_after: Includes 9,601 restricted units granted under the Equity Incentive Plan. Each restricted unit represents the right to receive one share of Class A Common Stock upon vesting. The restricted units vest in installments in accordance with the applicable restricted unit award agreement. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:44 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 12,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-20-000057 · wf-form4_159658463472645.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,601 Underlying: Common Stock · 12,601 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on July 31, 2020, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of such share on the settlement date). The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 3,360 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-078804 · a4.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,360 Underlying: Common Stock · 3,360 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · shares: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the issuer's Annual Meeting of Shareholders. F4 · derivative.exercise_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. F5 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 2,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-078804 · a4.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,300 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. Read SEC document |
| June 26, 2020 Filed Jun 30, 2020 18:02 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-078804 · a4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares received upon vesting of restricted stock units on June 26, 2020. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| June 08, 2020 Filed Jun 8, 2020 22:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 4,510 | $124.96 | $563,591.25 |
DisclosureSEC source: 0001127602-20-019158 · form4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,490 F1 · price: This transaction was executed in multiple trades at prices ranging from $124.9401 to $124.9656. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 23:40 UTC | Ares Management Corp ARES · Entity 3048 | GrantClass A Common Stock | 2,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-041908 · a4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,313 F1 · balance_after: Includes a grant of 2,805 restricted units granted on July 23, 2019, each of which represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse in three equal installments on July 23, 2020, 2021 and 2022. Also includes a grant of 13,761 restricted units granted on May 1, 2018, each of which represents the right to receive one share of Class A Common Stock upon vesting. The restrictions on such units are scheduled to lapse in three equal installments on May 1, 2019, 2020 and 2021. In connection with the vesting event on May 1, 2019, the reporting person received 4,587 shares of Class A Common Stock. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:20 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Units · Derivative | 1,870 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023021 · form4.xml · derivative · entry 4 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F8 · derivative.exercise_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. F8 · derivative.expiration_date: The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:20 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 6,310 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001127602-19-023021 · form4.xml · derivative · entry 3 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,310 Underlying: Common Stock · 6,310 shares Expires 2029-06-26 F5 · shares: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F6 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:20 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Units · Derivative | 2,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023021 · form4.xml · derivative · entry 2 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 2,300 shares Expires 2029-06-26 F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · shares: Annual non-employee director grant of restricted stock units, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders. F4 · derivative.exercise_date: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Read SEC document |
| June 26, 2019 Filed Jun 28, 2019 20:20 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-023021 · form4.xml · nonDerivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares received upon vesting of restricted stock units on June 26, 2019. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| May 16, 2019 Filed May 20, 2019 19:34 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 12,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-19-000043 · wf-form4_155838084657126.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,567 Underlying: Common Stock · 12,567 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on May 16, 2019, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of such share on the settlement date). The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 20:10 UTC | MATTEL INC /DE/ MAT · Entity 1046 | GrantRestricted Stock Units · Derivative | 6,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001523711-18-000076 · wf-form4_153695583246129.xml · derivative · entry 1 Olian Judy D. · CIK 0001605729 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,518 Underlying: Common Stock · 6,518 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") were granted on September 13, 2018, pursuant to the Mattel, Inc. Amended and Restated 2010 Equity and Long-Term Compensation Plan, as amended. Each RSU represents a contingent right to receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of such share on the settlement date). The RSUs are accompanied by dividend equivalent rights. F2 · derivative.exercise_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The RSUs are fully vested on the date of grant. Vested RSUs generally will be settled on the third anniversary of the date of grant. On the settlement date, for each vested RSU, the Reporting Person will receive one share of Common Stock (or, at the election of Mattel, Inc., a cash amount equal to the fair market value of one share of Common Stock on the settlement date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.